Bayer Cropscience · NSE: BAYERCROP · BSE: 506285
Q4 FY22 results · Jan–Mar 2022
Bayer Cropscience reported revenue from operations of ₹963.30 crore (up 31.3% from Q4 FY21) and net profit of ₹152.70 crore (up 146.7% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a standalone basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 963.30 | 733.70 | +31.3% | 990.10 | −2.7% |
| Other income | 15.70 | 15.90 | −1.3% | 9.80 | +60.2% |
| Total income | 979.00 | 749.60 | +30.6% | 999.90 | −2.1% |
| Profit before tax | 189.50 | 79.80 | +137.5% | 117.80 | +60.9% |
| Net profit for the period | 152.70 | 61.90 | +146.7% | 84.80 | +80.1% |
| EPS, basic (₹) | 33.97 | 13.77 | +146.7% | 18.87 | +80.0% |
| Net margin (%) | 15.9 | 8.4 | 8.6 |
Standalone
- Filed with BSE
- 25 May 2022, 18:42 IST
- Board meeting
- 24 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE